Balanced news tone
News Sentiment
HRMY sentiment intelligence
Harmony Biosciences Holdings news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-3.4% over one week, +10.4% over four weeks, trend inactive, and near fair-value range.
Harmony Biosciences Stock - Analyst consensus and technical backdrop
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Harmony Biosciences Shareholders Approve Governance Measures at Meeting
Harmony Biosciences Holdings (HRMY) shareholders recently approved key governance measures at their 2026 Annual Meeting. They elected four Class III directors, ratified Deloitte & Touche LLP as the independent auditor, and endorsed executive compensation, indicating strong shareh
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 14 May 2026 23:40
- Source
- TipRanks
Investors Can Find Comfort In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings Quality
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Harmony Biosciences Holdings, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Harmony Biosciences Holdings HRMY Margin Compression Challenges Bullish Valuation Narratives
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Market source
Should Harmony Biosciences’ Softer Q1 2026 Earnings and Upbeat Forecasts Require Action From HRMY Investors?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Assessing Harmony Biosciences (HRMY) Valuation After Recent Share Price Momentum And Pipeline Expectations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- Market source
Is It Time To Revisit Harmony Biosciences Holdings (HRMY) After Its Recent Share Price Rebound?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- simplywall.st
Harmony Biosciences: Four More Wakix Years, Nothing Visible Beyond (NASDAQ:HRMY)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- Seeking Alpha
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Market source
HARMONY BIOSCIENCES ($HRMY) Releases Q4 2025 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Feb 2026 08:00
- Source
- Quiver Quantitative
Harmony Biosciences Gains Pediatric WAKIX Approval As Valuation Draws Attention
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 17 Feb 2026 08:00
- Source
- simplywall.st
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Feb 2026 08:00
- Source
- Market source
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- The Motley Fool
Should Value Investors Buy Harmony Biosciences (HRMY) Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Jan 2026 08:00
- Source
- Market source
Is Harmony Biosciences (HRMY) Pricing Reflect Future Growth After Recent Mixed Share Performance
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jan 2026 08:00
- Source
- Market source
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Dec 2025 08:00
- Source
- simplywall.st
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 28% Share Price Climb
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- simplywall.st